2013 American Transplant Congress
Long-Term Safety and Effectiveness of Inhibitors of the Mammalian Target of Rapamycin in De Novo Kidney Transplantation: 10 Years of a Single Center Experience
Nephrology Division, Hospital do Rim e Hipertensão, São Paulo, Brazil
Introduction: The aim of this study was to evaluate long-term safety outcomes of de novo kidney transplant recipients who received MTORi [sirolimus (SRL) or Everolimus…2013 American Transplant Congress
PTC Taste Status and TAS2R38 Genotype as a Possible Indicator for Alcohol Use in Liver Transplant Patients
Background: Tasting compounds as bitter is genetically determined. Phenylthiocarbamide (PTC) tastes bitter to some or tasteless to others and has been linked to food preference.…2013 American Transplant Congress
Immunosuppression after Renal Allograft Failure: A Survey of US Practices
Little data exists to guide the management of immunosuppression after renal graft failure. More aggressive tapering of immunosuppressive medications may reduce the risk of infection,…2013 American Transplant Congress
Systematic Study of Causes of Death and Allograft Loss in Pancreas Transplantation in the Modern Era with ATG Induction and Tacrolimus Based Triple Immunosuppression
Endocrinology, Mayo Clinic, Rochester, MN
Background: Improved surgical techniques, modern immunosuppressive regimens, and a better understanding of donor and recipient risk factors have led to excellent short-term graft survival after…2013 American Transplant Congress
Impaired Effector/Memory CD8+ T Cell Response Delays Acute Allograft Rejection in Older Recipients
Surgery, Brigham and Women's Hospital, Boston, MA
Background: Over the past decade, the proportion of patients over the age of 65, both, waiting for and receiving transplants has increased dramatically. It is…2013 American Transplant Congress
Impact of Deceased Donor Intensive Care Unit Management Parameters on Early Liver Graft Function
Transplant Division, Dept of Surgery, Indiana University School of Medicine, Indianapolis, IN
Objective:The Indiana Organ Procurement Organization (IOPO) has adopted deceased donor intensive care unit (ICU) management parameters to optimize placement of transplant organs. It is unknown…2013 American Transplant Congress
Dissecting the Contribution of Cross-Reactivity to the Preformed T Cell Response to Donor-Alloantigen in HIV+ Kidney and Liver Transplant Patients
Department of Surgery, University of California San Francisco, San Francisco, CA
Background: Despite immunodeficiency of CD4+ T cells, HIV+ kidney and liver transplant patients experience higher rejection rates compared to HIV- patients. Most of the rejection…2013 American Transplant Congress
Creatinine (Creat) and Cystatin C (CysC) Based Glomerular Filtration Rate (GFR) Estimating Equations Are More Precise Than Creatinine-Only-Based Equations in Former Living Kidney Donors
Background: The application of GFR estimating equations and classification schema for chronic kidney disease (CKD) has inadvertently led to labeling of some former living kidney…2013 American Transplant Congress
Early Protocol Biopsies Can Identify Antibody-Mediated Rejection in Sensitized Patients
Renal Transplant Service, Hospital das Clinicas University of São Paulo, São Paulo, Brazil
HLA sensitized patients are at risk for antibody-mediated rejection (ABMR). Our purpose was to evaluate the importance of early protocol biopsies. From Jul/2010 to Jun/2012,…2013 American Transplant Congress
Incidence of Subclinical Rejection and De Novo Donor Specific Antibodies in Calcineurin Sparing Regimens
Introduction: The incidence and impact of subclinical acute rejection (SCR) and of emergence of donor specific antibodies (DSA) on renal graft function remains poorly understood,…
American Transplant Congress abstracts